Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes

Detection of androgen receptor (AR) variant 7 (AR-V7) is emerging as a clinically important biomarker in castrate resistant prostate cancer (CRPC). Detection is possible from tumor tissue, which is often inaccessible in the advanced disease setting. With recent progress in detecting AR-V7 in circula...

Full description

Bibliographic Details
Main Authors: Mohammed Nimir, Yafeng Ma, Sarah A. Jeffreys, Thomas Opperman, Francis Young, Tanzila Khan, Pei Ding, Wei Chua, Bavanthi Balakrishnar, Adam Cooper, Paul De Souza, Therese M. Becker
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cells
Subjects:
CTC
AR
Online Access:https://www.mdpi.com/2073-4409/8/7/688